The Resonance Health (ASX:RHT) share price has rocketed up 9% today. Here’s why.

The Resonance Health Limited (ASX: RHT) share price is soaring today after the company announced an agreement involving its flagship artificial intelligence (AI) device.

The Resonance Health share price has surged up 9.3% to trade at 23.5 cents at the time of writing.

What’s the deal?

In today’s release, Resonance Health advised that its HepaFat-AI device, which assesses fatty-liver using AI, was being incorporated into its Blackford Analysis Agreement.

The news comes as HepaFat-AI recently received regulatory clearance from the US food and drug administration (FDA) allowing Resonance to commercially sell its flagship product in the US.

Blackford delivers platforms and services for the use of medical imaging applications and AI…